Centre hospitalier Lyon Sud-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents

    Journal of Clinical Oncology, Vol. 35, Núm. 14, pp. 1591-1597